Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
Artificial Intelligence in Drug Discovery
May 14, 2018
PODCASTERS
“Get knowledge and inspiration to apply artificial intelligence to drug development. Discover startups applying machine learning to biomedical research. Hear how biotech and pharma companies use AI to speed discovery and cut costs. Learn from academic researchers pushing boundaries in applying computation to biology. We interview leaders transforming drug development with data and algorithms. Subscribe now and never miss an episode!”
A podcast on Spotify for Podcasters: The podcasts explores the transformative role of artificial intelligence (AI) in drug discovery, particularly emphasizing the efforts of the company FDNA. FDNA leverages AI to accelerate the identification and development of new pharmaceuticals, aiming to make the drug discovery process faster, more cost-effective, and more efficient. The podcast delves into various AI technologies and methodologies that can pinpoint potential drug candidates, predict their efficacy, and identify possible side effects, ultimately revolutionizing the traditional paradigms in pharmaceutical research and development.
Related articles
Continue reading
Interview with Dr. Giulia Pascolini: Unravelling the Genetic Underpinnings of Dermatological Anomalies
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Spanish Coffin Siris Syndrome Association: Fighting for Health and Recognition
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…